Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts
Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts
專家展望：nurix therapeutics的14位分析師觀點
In the last three months, 14 analysts have published ratings on Nurix Therapeutics (NASDAQ:NRIX), offering a diverse range of perspectives from bullish to bearish.
在過去三個月中，共有14位分析師對Nurix Therapeutics（NASDAQ：NRIX）進行了評級，在看好和看淡等各種角度上提供了不同的觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Nurix Therapeutics, presenting an average target of $28.5, a high estimate of $35.00, and a low estimate of $20.00. Witnessing a positive shift, the current average has risen by 4.28% from the previous average price target of $27.33.
在對12個月價格目標的評估中，分析師揭示了Nurix Therapeutics的見解，呈現出28.5美元的平均目標，35.00美元的高估值和20.00美元的低估值。當前平均價格目標已比之前的平均價格目標27.33美元上漲了4.28%。
Decoding Analyst Ratings: A Detailed Look
分析師評級解讀：詳細解析
The standing of Nurix...
通過對最...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。